What is adaptive therapy? (for example, zytiga which moffitt tested)

What is Adaptive Therapy?

Great question! Adaptive therapy is an innovative treatment approach that's quite different from standard cancer treatment schedules. Let me explain how it works and what makes it unique.

---

How Standard Treatment Works (vs. Adaptive Therapy)

Traditional approach: Patients receive chemotherapy or hormone therapy on a fixed schedule—for example, taking a drug continuously or in regular cycles, regardless of how well it's working.

Adaptive therapy approach: Treatment is adjusted based on how your cancer responds. The goal is to:

• Give you the drug when you need it
• Pause or reduce the drug when your cancer is responding well
• Restart when signs of resistance appear
• Potentially reduce side effects and toxicity over time

---

Adaptive Therapy with Hormone Drugs Like Zytiga (Abiraterone)

For prostate cancer patients on hormone therapies like Zytiga (abiraterone), adaptive therapy means:

The Clinical Reasoning: Doctors know that cancer cells eventually develop resistance to hormone therapy. Traditional treatment tries to prevent this by keeping drug levels constant. Adaptive therapy takes a different approach: by strategically pausing treatment when PSA (prostate-specific antigen) levels drop significantly, you may:

• Delay the development of drug-resistant cancer cells
• Give your body a break from side effects
• Potentially extend how long the drug remains effective

How it might work in practice:

1. Start Zytiga on a regular schedule
2. Monitor PSA levels closely
3. When PSA drops to a target level, pause the medication
4. Continue monitoring PSA
5. Restart Zytiga if PSA begins rising again
6. Repeat this cycle

---

Why Moffitt and Other Centers Are Testing This

According to the Cancer Patient Lab webinar on advanced prostate cancer, centers like Moffitt Cancer Center are exploring innovative approaches to extend treatment effectiveness. The rationale is:

• Reduce cumulative toxicity — fewer continuous side effects means better quality of life and ability to tolerate future treatments
• Delay resistance — cancer cells may be less likely to develop resistance if the drug pressure is intermittent rather than constant
• Personalized dosing — treatment is tailored to YOUR cancer's response, not a one-size-fits-all schedule

---

Important Context

Adaptive therapy is still being studied and refined. It's not yet standard of care for all prostate cancer patients, but research is ongoing at major cancer centers. The approach requires:

• Frequent monitoring (regular PSA blood tests and imaging)
• Close communication with your oncology team
• Patient engagement in the decision-making process
• Access to specialized centers that offer this approach

---

Questions to Ask Your Oncologist

If you're interested in adaptive therapy approaches:

1. "Is adaptive therapy an option for my specific situation and stage of prostate cancer?"
2. "What evidence exists for adaptive therapy with [your specific drug]?"
3. "How frequently would I need monitoring if we pursued an adaptive approach?"
4. "What are the potential benefits and risks compared to continuous treatment?"
5. "Are there clinical trials at your center or nearby that are testing adaptive therapy?"

---

Authoritative Sources

According to the Cancer Patient Lab Molecular Tumor Board discussion featuring advanced prostate cancer experts, innovative treatment approaches—including modified dosing schedules and treatment pauses—are being explored at major centers like MD Anderson, Memorial Sloan Kettering, and Moffitt Cancer Center for patients with treatment-resistant disease.

The NCCN Guidelines for Prostate Cancer continue to evolve as new evidence emerges about optimizing hormone therapy and chemotherapy sequencing for individual patients.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.